← Open Payments lookup

CARLOS SOLIS: Open Payments

NPI 1922657584 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$738 in 32 payments from 11 companies in 2025. Trend: 2023 $435 · 2024 $391 · 2025 $738

Food & beverage: $738
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$129
Merck Sharp & Dohme LLC4$123
ABBVIE INC.6$105
Baxter Healthcare2$75
Takeda Pharmaceuticals U.S.A., Inc.3$71
Madrigal Pharmaceuticals4$67
Mallinckrodt Hospital Products Inc.2$51
Genentech USA, Inc.2$46
La Jolla Pharmaceutical Company1$29
Pacira Pharmaceuticals Incorporated1$26

Products named: XIFAXAN, ZERBAXA, TEFLARO, PERCLOT, LIVTENCITY, REZDIFFRA, TERLIVAZ, Tecentriq.

Industry payments across TX — which companies pay providers there.